These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34367979)

  • 1. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2019; 9():1156. PubMed ID: 31750247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
    Jesenko T; Brezar SK; Cemazar M; Biasin A; Tierno D; Scaggiante B; Grassi M; Grassi C; Dapas B; Truong NH; Abrami M; Zanconati F; Bonazza D; Rizzolio F; Parisi S; Pastorin G; Grassi G
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2020; 10():277. PubMed ID: 32195187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N
    Ma H; Hong Y; Xu Z; Weng Z; Yang Y; Jin D; Chen Z; Yue J; Zhou X; Xu Z; Fei F; Li J; Song W
    Biomed Pharmacother; 2024 Apr; 173():116365. PubMed ID: 38452654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma.
    Manna D; Sarkar D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
    Wang W; Hao LP; Song H; Chu XY; Wang R
    Front Oncol; 2022; 12():790916. PubMed ID: 35280805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells.
    Lin JC; Yang PM; Liu TP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
    Chen T
    J Hepatocell Carcinoma; 2022; 9():1029-1040. PubMed ID: 36132427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
    Lai Y; Huang H; Abudoureyimu M; Lin X; Tian C; Wang T; Chu X; Wang R
    Am J Cancer Res; 2020; 10(12):4066-4084. PubMed ID: 33414986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.
    Kanthaje S; Makol A; Chakraborti A
    Hepatol Res; 2018 Jan; 48(1):5-14. PubMed ID: 29055114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNA and Long Non-Coding RNA in Hepatocellular Carcinoma.
    Gupta M; Chandan K; Sarwat M
    Curr Pharm Des; 2020; 26(4):415-428. PubMed ID: 31939724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324.
    Weng H; Zeng L; Cao L; Chen T; Li Y; Xu Y; Peng Y; Ye Y
    Mol Ther Nucleic Acids; 2021 Mar; 23():811-820. PubMed ID: 33614231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.